Allergan Plc (AGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2017 | 06-2017 | 03-2017 | 12-2016 | 09-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,242,100 | -3,227,500 | -2,564,200 | 14,979,500 | 14,978,300 |
| Depreciation Amortization | 5,543,900 | 3,676,100 | 1,812,200 | 6,724,400 | 5,041,300 |
| Income taxes - deferred | -3,205,300 | -1,478,800 | -712,800 | -1,443,900 | -517,100 |
| Accounts receivable | -138,500 | -139,000 | 53,200 | -191,000 | -40,400 |
| Other Working Capital | 93,400 | 230,000 | -235,800 | -726,500 | -300,300 |
| Other Operating Activity | 8,944,100 | 3,533,800 | 2,370,700 | -17,896,800 | -17,626,600 |
| Operating Cash Flow | $3,995,500 | $2,594,600 | $723,300 | $1,445,700 | $1,535,200 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 14,474,400 | 13,197,500 | 9,655,300 | N/A | N/A |
| PPE Investments | -228,200 | -132,900 | -32,500 | -298,100 | -217,200 |
| Net Acquisitions | -5,290,400 | -5,290,400 | -2,874,400 | 32,605,300 | 33,230,000 |
| Purchase Of Investment | -8,433,800 | -6,787,900 | -6,387,900 | -15,743,500 | -15,445,500 |
| Purchase Sale Intangibles | -604,300 | -586,300 | -346,300 | -2,000 | 0 |
| Other Investing Activity | -604,300 | -586,300 | -346,300 | 7,769,600 | 40,000 |
| Investing Cash Flow | $-82,300 | $400,000 | $14,200 | $24,333,300 | $17,607,300 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | -2,554,200 | 3,023,000 | 0 | 1,050,000 | -9,781,000 |
| Debt Repayment | N/A | -5,579,200 | -1,015,900 | -10,848,700 | N/A |
| Common Stock Issued | 167,200 | N/A | 52,600 | 172,100 | 138,000 |
| Common Stock Repurchased | -36,400 | N/A | -29,500 | -15,076,400 | -2,758,600 |
| Dividend Paid | -917,000 | -611,900 | -305,800 | -278,400 | -208,800 |
| Other Financing Activity | -703,200 | -693,100 | -76,300 | -161,100 | -77,700 |
| Financing Cash Flow | $-4,043,600 | $-3,861,200 | $-1,374,900 | $-25,142,500 | $-12,688,100 |
| Exchange Rate Effect | 19,100 | 11,500 | 6,300 | -8,500 | 4,300 |
| Beginning Cash Position | 1,724,000 | 1,713,200 | 1,724,000 | 1,096,000 | 1,096,000 |
| End Cash Position | 1,612,700 | 858,100 | 1,092,900 | 1,724,000 | 7,554,700 |
| Net Cash Flow | $-111,300 | $-855,100 | $-631,100 | $628,000 | $6,458,700 |
| Free Cash Flow | |||||
| Operating Cash Flow | 3,995,500 | 2,594,600 | 723,300 | 1,445,700 | 1,535,200 |
| Capital Expenditure | -234,000 | -137,200 | -33,200 | -331,400 | -250,500 |
| Free Cash Flow | 3,761,500 | 2,457,400 | 690,100 | 1,114,300 | 1,284,700 |